Status Epilepticus Revealing Creutzfeldt-Jakob Disease: A Case Report

Article Sidebar

PDF Download
Published Aug 30, 2023
DOI: https://doi.org/10.18103/mra.v11i8.3932

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Mabchour E
1. Departement of intensive care medicine, ibn rochd university hospital, faculty of medicine and pharmacy of casablanca, Hassan 2 university, Casablanca, Morocco.
Maghrabi O
1. Departement of intensive care medicine, ibn rochd university hospital, faculty of medicine and pharmacy of casablanca, Hassan 2 university, Casablanca, Morocco.
Machrouh W
1. Departement of intensive care medicine, ibn rochd university hospital, faculty of medicine and pharmacy of casablanca, Hassan 2 university, Casablanca, Morocco.
Charra B
head of department of medical intensive care, ibn rochd university hospital

Abstract

Creutzfeldt-Jakob disease (CJD) is a rare neurodegenerative disease of undetermined etiology, In Creutzfeldt-Jakob syndrome the symptomatology is quite variable and it  consist of predominantly progressive dementia with a rapid onset, myoclonus, and also cerebellar, pyramidal, extrapyramidal and visual signs, the evolution of this disease is uniformly fatal, most patients die within 12 months, we present a case of a 72 year old women, who was admitted for a status epilepticus, She was later diagnosed with sporadic CJD.

Keywords: Creutzfeldt-Jakob, status epilepticus, case report

Article Details

How to Cite
E, Mabchour et al. Status Epilepticus Revealing Creutzfeldt-Jakob Disease: A Case Report. Medical Research Archives, [S.l.], v. 11, n. 8, aug. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3932>. Date accessed: 13 may 2024. doi: https://doi.org/10.18103/mra.v11i8.3932.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 11 No 8 (2023): August Issue, Vol.11, Issue 8
Section
Case Reports

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Appleby BS, Appleby KK, Rabins PV. Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years. J Neuropsychiatry Clin Neurosci. 2007;19(4):428–435.
2. Trachtenbroit I, Cohen OS, Chapman J, Rosenmann H, Nitsan Z, Kahana E, et al. Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease. Neurol Sci. 2022;43(7):4275–4279.
3. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39(6):767–778.
4. Mackenzie G, Will R. Creutzfeldt-Jakob disease: recent developments. F1000Res. 2017;6:2053.
5. Brandel J-P. Les maladies à prions ou encéphalopathies spongiformes transmissibles. La Revue de Médecine Interne. 2022;43(2):106–115.
6. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–1591.
7. Parry J, Tuch P, Knezevic W, Fabian V. Creutzfeldt-Jakob syndrome presenting as epilepsia partialis continua. Journal of Clinical Neuroscience. 2001;8(3):266–268.
8. Court L, Bert J. [Electrophysiology of transmissible encephalopathies]. Pathol Biol (Paris). 1995;43(1):25–42.
9. Espinosa PS, Bensalem-Owen MK, Fee DB. Sporadic Creutzfeldt–Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clinical Neurology and Neurosurgery. 2010;112(6):537–540.
10. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63(3):443–449.
11. Beaudry P, Cohen P, Brandel JP, Delasnerie-Lauprêtre N, Richard S, Launay JM, et al. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 1999;10(1):40–46.
12. Appleby BS, Shetty S, Elkasaby M. Genetic aspects of human prion diseases. Front Neurol. 2022;13:1003056.
13. Hermann P, Appleby B, Brandel J-P, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20(3):235–246.